中美天津史克制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
24
NMPA:24
Drug Approvals
Ibuprofen Chewable Tablets
- Product Name
- 布洛芬咀嚼片
- Approval Number
- 国药准字H20140018
- Approval Date
- Aug 23, 2023
NMPA
Paracetamol and Caffeine Tablets
- Product Name
- 酚咖片
- Approval Number
- 国药准字H20066878
- Approval Date
- Dec 16, 2020
NMPA
Diclofenac Sodium Sustained Release Tablets
- Product Name
- 扶他林
- Approval Number
- 国药准字H10980297
- Approval Date
- May 28, 2020
NMPA
Diclofenac Sodium Enteric-coated Tablets
- Product Name
- 扶他林
- Approval Number
- 国药准字H11021640
- Approval Date
- May 28, 2020
NMPA
Ibuprofen and Pseudoephedrine HCL Sustained Release Capsules
- Product Name
- 布洛伪麻缓释胶囊
- Approval Number
- 国药准字H20051079
- Approval Date
- Apr 7, 2020
NMPA
Ibuprofen Sustained Release Capsules
- Product Name
- 布洛芬缓释胶囊
- Approval Number
- 国药准字H20013062
- Approval Date
- Apr 7, 2020
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found